Search Results

TraceLink Inc ., the leading digital platform company for the life sciences industry, today announced that, for the fifth consecutive year, Shabbir Dahod , president and CEO of TraceLink, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14 at 8:40 am EST via virtual webcast.

Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on Peptides such as GLP-1 Weight Management, Hormone Health, Longevity and Sexual Wellness Key Highlights: • Target generated approximately $12.7 million in revenue for the trailing twelve months ended August 2026 (unaudited, as provided by Target management) and is cash-flow positive • Proposed purchase price of approximately $15 million, payable in cash and KALA stock; the cash portion is expected to be funded from existing balance sheet resources • Founded in 2023; LegitScript-certified, NABP-accredited platform serving clients in all 50 states; more than 90,000 clients served since inception • 45-day due diligence period expected to conclude in November 2026; definitive agreements and closing targeted for late 2026 or early 2027

TraceLink Inc., the leading digital platform company for the life science supply chain, announced it has earned ISO 9001:2015 certification, a globally recognized quality management standard.

TraceLink Inc., the leading digital platform company for the life sciences supply chain, today announced that Henry Schein, the world’s largest provider of health care solutions to office-based dental and medical practitioners, has implemented TraceLink’s verification router service (VRS) solution.

TraceLink Inc., the leading digital platform company for the life sciences industry, announced the first round of grant recipients in response to the Company’s commitment to a total of $1 Million in charitable funding for COVID-19 relief efforts to eligible organizations around the world.